Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resminostat for Maintenance in Advanced Mycosis Fungoides or Sézary Syndrome
NCT02953301Phase 2Completed
- Sponsor
- 4SC AG
- Start
- Nov 2016
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of Resminostat in mycosis fungoides (MF), Sézary syndrome (SS), sponsored by 4SC AG. Started Nov 2016; status: completed.
02
Drugs
Resminostat
03
Conditions
mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT02953301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953301.